Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-10-14

Clinical Trial Update: Evaluation of Non-cultured Epidermal Cellular Grafting vs Hyaluronic Acid for Repigmenting Vitiligo and Piebaldism [Phase 3]

View source ↗

Summary

Phase 3 trial comparing non-cultured epidermal cellular grafting to hyaluronic acid for repigmentation in vitiligo and piebaldism; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hyaluronic acid (hyaluronic acid)
  • Non-cultured Epidermal Cellular Grafting

Snippet

Sponsor: Laboratoires Genévrier | Conditions: Vitiligo, Piebaldism | Phase 3 | Status: COMPLETED